Paula Soteropoulos
CIK 1692444 · Chief Executive Officer · last filed 2026-05-22
Paula Soteropoulos is a Chief Executive Officer who has filed 39 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for DNTH, was dated May 22, 2026. Across all open-market trades the lifetime net is −$5.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $557.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$557.0K
4
39
-$5.79M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNTH | Director | 0 | $82.07 | $0 | -$2.25M | 7 | 2026-05-22 |
| RLYB | Director | — | $15.92 | — | $0 | 5 | 2025-05-15 |
| QURE | Director | 20,203 | $27.57 | $557.0K | -$1.92M | 22 | 2024-06-17 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Chief Executive Officer | 1,711,079 | — | — | -$1.61M | 5 | 2019-09-30 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2026-05-11 | DNTH | Mixed | — | -$46.1K | EDGAR |
| 2026-04-01 | DNTH | Mixed | — | -$42.9K | EDGAR |
| 2026-03-26 | DNTH | Mixed | — | -$1.92M | EDGAR |
| 2025-05-22 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2025-05-15 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | QURE | Sell (S) | −2,220 | -$11.4K | EDGAR |
| 2024-05-28 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | RLYB | Grant (A) | — | $0 | EDGAR |
| 2023-09-13 | DNTH | Grant (A) | — | $0 | EDGAR |